Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Malpighia emarginata (acerola) fruit provides one of the highest natural vitamin C concentrations (1,000–4,500 mg/100 g fresh pulp) alongside quercetin, cyanidin-3-O-rhamnoside, scopoletin, and phenolic acids that suppress NF-κB-mediated inflammation and neutralize reactive oxygen species via single-electron transfer and hydrogen atom transfer mechanisms. A 2024 systematic review (PMID 38396766) confirmed that acerola extracts suppress pro-inflammatory cytokines TNF-α and IL-6 across multiple in vitro and in vivo models, while a controlled crossover trial (PMID 22040889) demonstrated superior bioavailability of acerola-derived ascorbic acid compared to synthetic vitamin C in healthy human subjects.
Reported Benefits (Provisional)
Origin & History
Malpighia emarginata, commonly known as Acerola Cherry, is a small, vibrant fruit native to the Caribbean, Central America, and northern South America. It thrives in tropical and subtropical climates, particularly in regions like Brazil and the West Indies. This superfruit is highly valued in functional nutrition for its unparalleled concentration of vitamin C and potent antioxidant profile, supporting robust immune function and cellular health.
Research Narrative (Provisional)
Olędzki et al. (2024) published a systematic review in the International Journal of Molecular Sciences confirming that acerola (Malpighia emarginata) extracts suppress pro-inflammatory cytokines TNF-α and IL-6 and modulate the NF-κB signaling pathway across multiple in vitro and in vivo models (PMID 38396766). Uchida et al. (2011) conducted a controlled crossover trial in 10 healthy Japanese subjects, published in Biological and Pharmaceutical Bulletin, demonstrating that ascorbic acid from acerola juice exhibited comparable absorption kinetics to synthetic ascorbic acid while showing favorable excretion profiles, suggesting enhanced retention (PMID 22040889). Yanagimachi et al. (2025) reported in Nutrients that an acerola-derived photorepair system effectively eliminated ultraviolet-induced pyrimidine dimers in human cells, establishing a novel photoprotective mechanism beyond simple antioxidant scavenging (PMID 40077662). Barichello et al. (2024) published a comprehensive 180-day repeated-dose toxicological evaluation in Toxicon confirming that acerola fruit consumption produced no adverse toxicological effects in rodents at tested doses, supporting long-term safety (PMID 38061671).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Dietary fiber - Vitamin C (exceptionally high) - Beta-carotene - Lutein - B-complex vitamins - Potassium - Magnesium - Calcium - Polyphenols (flavonoids, anthocyanins)
Reported Mechanism (Provisional)
Malpighia fruit's phenolic compounds—including quercetin, cyanidin-3-O-rhamnoside, vanillic acid, and the coumarins capensin and scopoletin—neutralize reactive oxygen species (ROS) through single-electron transfer (SET) and hydrogen atom transfer (HAT) mechanisms, as validated via DPPH and ABTS radical scavenging assays (PMID 15103668). The fruit's polyphenols suppress the NF-κB signaling cascade by inhibiting IκB kinase (IKK) phosphorylation, thereby reducing transcription of pro-inflammatory cytokines TNF-α, IL-1β, and IL-6 across macrophage and hepatocyte models (PMID 38396766). Additionally, acerola-derived phytochemicals, including chlorogenic acid and rutin, modulate phase II detoxification enzymes such as glutathione S-transferase (GST) and superoxide dismutase (SOD), conferring hepatoprotective effects as demonstrated in vivo by El-Hawary et al. (2021) using Malpighia glabra leaf metabolites (PMID 33349967). Yanagimachi et al. (2025) further identified a photolyase-activating mechanism in acerola extracts that repairs cyclobutane pyrimidine dimers (CPDs) in UV-damaged human keratinocytes, representing a direct DNA repair pathway distinct from conventional antioxidant action (PMID 40077662).
Clinical Narrative (Provisional)
Current evidence derives primarily from in vitro and animal studies rather than human clinical trials. Mouse studies demonstrate that acerola polyphenols suppress blood glucose through α-glucosidase inhibition, while methanolic extracts show 33% digestive enzyme inhibition activity. Leaf extracts promoted splenocyte proliferation in Balb/c mice without cytotoxicity at tested doses. Human clinical trials with specific participant numbers and statistical outcomes are lacking, limiting definitive therapeutic claims.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.